{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:32:05Z","timestamp":1761921125318,"version":"3.41.2"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T00:00:00Z","timestamp":1683590400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Allergy"],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Allergic reactions to insulin have become very rare with the introduction of human insulin. Anaphylaxis is a life-threatening condition that results from immediate IgE-mediated hypersensitivity. Desensitization to human insulin was reported to control immediate hypersensitivity reactions to insulin. Here, we describe the history and challenges of managing our patient and the development of an insulin desensitization protocol in a resource-limited setup.<\/jats:p><\/jats:sec><jats:sec><jats:title>Case Summary<\/jats:title><jats:p>A 42-year-old Sudanese woman with poorly controlled type 2 diabetes on maximum antidiabetic medications required insulin therapy to achieve reasonable glycemic control. She developed progressive and severe immediate hypersensitivity reactions to insulin, including anaphylaxis. Serum sample analysis demonstrated insulin-specific IgE antibodies. The patient's poor glycemic control and the need for breast surgery indicated insulin desensitization. A 4-day desensitization protocol was delivered in an ICU bed for close observation. Following successful desensitization and 24-h observation, our patient was discharged on pre-meal human insulin, which was tolerated well to the current date<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Although insulin allergy is rare, once encountered, it is very challenging in patients who have no other treatment options available. Different protocols for insulin desensitization are described in the literature; the agreed protocol was implemented successfully in our patient despite the limited resources.<\/jats:p><\/jats:sec>","DOI":"10.3389\/falgy.2023.1089966","type":"journal-article","created":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T05:33:29Z","timestamp":1683610409000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Case report: Insulin desensitization as the only option for managing insulin allergy in a Sudanese patient"],"prefix":"10.3389","volume":"4","author":[{"given":"Rihan","family":"Said","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rayan","family":"Goda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ihab B.","family":"Abdalrahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nahla H. H.","family":"Erwa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,9]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1046\/J.1398-9995.2003.00324.X","article-title":"Allergy to human insulin","volume":"58","author":"Fern\u00e1ndez","year":"2003","journal-title":"Allergy"},{"key":"B2","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/J.CLINDERMATOL.2010.11.009","article-title":"Insulin allergy","volume":"29","author":"Ghazavi","year":"2011","journal-title":"Clin Dermatol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2337\/DIAB.10.2.105","article-title":"Anaphylactic shock following insulin injection: case report and review of the literature","volume":"10","author":"Hanauer","year":"1961","journal-title":"Diabetes"},{"key":"B4","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/0091-6749(76)90157-3","article-title":"Allergic reactions to insulin","volume":"58","author":"Lamkin","year":"1976","journal-title":"J Allergy Clin Immunol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.2337\/DIACARE.24.11.2008","article-title":"Human insulin analog insulin aspart does not cause insulin allergy","volume":"24","author":"Yasuda","year":"2001","journal-title":"Diabetes Care"},{"key":"B6","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1111\/J.1398-9995.2007.01567.X","article-title":"Insulin allergy: clinical manifestations and management strategies","volume":"63","author":"Heinzerling","year":"2008","journal-title":"Allergy"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/S13223-021-00554-1\/FIGURES\/3","article-title":"The complexities of insulin allergy: a case and approach","volume":"17","author":"Aberumand","year":"2021","journal-title":"Allergy, Asthma Clin Immunol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/DMRR.714","article-title":"Allergy reactions to insulin: effects of continuous subcutaneous insulin infusion and insulin analogues","volume":"23","author":"Radermecker","year":"2007","journal-title":"Diabetes Metab Res Rev"},{"key":"B9","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/J.1464-5491.2006.01811.X","article-title":"Insulin allergy in a patient with type 2 diabetes successfully treated with continuous subcutaneous insulin infusion","volume":"23","author":"Moyes","year":"2006","journal-title":"Diabet Med"},{"key":"B10","doi-asserted-by":"publisher","first-page":"983","DOI":"10.2337\/DIACARE.28.4.983","article-title":"Successful treatment of insulin allergy in a 1-year-old infant with neonatal diabetes by lispro and glargine insulin","volume":"28","author":"Kara","year":"2005","journal-title":"Diabetes Care"},{"key":"B11","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/S40259-020-00465-4","article-title":"Immunogenicity challenges associated with subcutaneous delivery of therapeutic proteins","volume":"35","author":"Jarvi","year":"2021","journal-title":"BioDrugs"},{"key":"B12","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1056\/NEJMC052463","article-title":"Immunologic tolerance to intravenously injected insulin","volume":"354","author":"Asai","year":"2006","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1016\/J.TRANSPROCEED.2005.05.020","article-title":"Pancreas transplantation for treatment of generalized allergy to human insulin in type 1 diabetes","volume":"37","author":"Malaise","year":"2005","journal-title":"Transplant Proc"},{"key":"B14","doi-asserted-by":"publisher","first-page":"311","DOI":"10.2500\/AAP.2020.41.200070","article-title":"Allergen immunotherapy: from bench research to clinical application","volume":"41","author":"Bellanti","year":"2020","journal-title":"Allergy Asthma Proc"},{"key":"B15","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1097\/ACI.0000000000000335","article-title":"Allergen immunotherapy: an updated review of safety","volume":"17","author":"James","year":"2017","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"B16","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1177\/1060028015625660","article-title":"Medication desensitization: characterization of outcomes and risk factors for reactions","volume":"50","author":"Murray","year":"2016","journal-title":"Ann Pharmacother"},{"key":"B17","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1016\/S0140-6736(46)90972-5","article-title":"Sensitivity to penicillin; anaphylaxis and desensitisation","volume":"2","author":"O\u2019Donovan","year":"1946","journal-title":"Lancet (London, England)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1186\/1752-1947-2-283","article-title":"Successful desensitization with human insulin in a patient with an insulin allergy and hypersensitivity to protamine: a case report","volume":"2","author":"Pf\u00f6hler","year":"2008","journal-title":"J Med Case Rep"},{"key":"B19","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1186\/s13601-018-0223-x","article-title":"Insulin allergy can be successfully managed by a systematic approach","volume":"8","author":"Haastrup","year":"2018","journal-title":"Clin Transl Allergy"},{"key":"B20","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1016\/S0140-6736(12)61719-X","article-title":"Age-specific and sex-specific mortality in 187 countries, 1970\u20132010: a systematic analysis for the global burden of disease study 2010","volume":"380","author":"Wang","year":"2012","journal-title":"Lancet (London, England)"}],"container-title":["Frontiers in Allergy"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2023.1089966\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,9]],"date-time":"2023-05-09T05:33:33Z","timestamp":1683610413000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/falgy.2023.1089966\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,9]]},"references-count":20,"alternative-id":["10.3389\/falgy.2023.1089966"],"URL":"https:\/\/doi.org\/10.3389\/falgy.2023.1089966","relation":{},"ISSN":["2673-6101"],"issn-type":[{"type":"electronic","value":"2673-6101"}],"subject":[],"published":{"date-parts":[[2023,5,9]]},"article-number":"1089966"}}